Drug Type Non-recombinant coagulation factor |
Synonyms 蜀阳茵源 |
Target |
Action stimulants |
Mechanism Fibrinogen stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (03 Nov 2021), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Afibrinogenemia | China | 03 Nov 2021 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acquired fibrinogen deficiency | Phase 3 | China | 01 Nov 2024 | |
Deficiency Diseases | Phase 3 | China | 27 Mar 2017 |